contraindications for glp-1 agonists include glp-1_analogs [TUSOM Mapping the effectiveness and risks

In all five clinical trials (SURPASS trials), Tirzepatide was the only medication to lower body weight (5.411.7 kg) in T2D when given weekly at doses of 515 mg [298]

Once your body adjusts, hair growth typically returns to normal

Mechanistically, the common thread appears to be dampening drug-evoked dopamine signaling in the nucleus accumbens and engaging GLP-1 anti-craving circuits involving the VTA, nucleus accumbens, lateral septum, laterodorsal tegmentum, and nucleus tractus solitarius

A summary of all the CV events occurring during these trials are presented in Additional file 1: Table S1

The effects of GLP-1 and dual agonists on lipid metabolism also provide a more complete treatment plan for metabolic diseases

Three distinct fragments of exendin 939 were found to reduce CAP-induced inward currents and calcium influx through TRPV1